165 related articles for article (PubMed ID: 8970522)
21. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
el-Shirbiny AM; Yeung H; Imbriaco M; Michaeli J; Macapinlac H; Larson SM
J Nucl Med; 1997 Aug; 38(8):1208-10. PubMed ID: 9255151
[TBL] [Abstract][Full Text] [Related]
22. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
23. Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism.
Sisson JC; Thompson NW; Ackerman RJ; Wahl RL
Radiology; 1994 Jul; 192(1):280. PubMed ID: 8208955
[No Abstract] [Full Text] [Related]
24. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
25. Providing optimal preoperative localization for recurrent parathyroid carcinoma: a combined parathyroid scintigraphy and computed tomography approach.
Clark P; Wooldridge T; Kleinpeter K; Perrier N; Lovato J; Morton K
Clin Nucl Med; 2004 Nov; 29(11):681-4. PubMed ID: 15483477
[TBL] [Abstract][Full Text] [Related]
26. [False negative of the scintigraphy with 99mTc-sestamibi in parathyroid carcinoma with associated brown tumors. Contributions of the 18F-FDG-PET/CT].
Santiago Chinchilla A; Ramos Font C; Muros de Fuentes MA; Navarro-Pelayo Láinez M; Palacios Gerona H; Moreno Caballero M; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(3):174-9. PubMed ID: 21342724
[TBL] [Abstract][Full Text] [Related]
27. The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
James C; Starks M; MacGillivray DC; White J
Surg Oncol Clin N Am; 1999 Jan; 8(1):145-69. PubMed ID: 9824366
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid adenoma localization by PET FDG.
Neumann DR; Esselstyn CB; MacIntyre WJ; Chen EQ; Go RT; Kohse LM
J Comput Assist Tomogr; 1993; 17(6):976-7. PubMed ID: 8227589
[TBL] [Abstract][Full Text] [Related]
29. [Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
Serrano J; Verdú J; Martínez A; Antón A; Caballero O
Rev Esp Med Nucl; 1998; 17(1):35-9. PubMed ID: 9609842
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
Nguyen BD
Radiographics; 1999; 19(3):601-14; discussion 615-6. PubMed ID: 10336191
[TBL] [Abstract][Full Text] [Related]
31. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
32. [Primary hyperparathyroidism due to parathyroid carcinoma].
Megino Moreno T; Herranz Antolín S; Bernal Bello D; Alvarez De Frutos V
Endocrinol Nutr; 2010 Dec; 57(10):504-6. PubMed ID: 20951655
[No Abstract] [Full Text] [Related]
33. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism.
Matwichuk CL; Taylor SM; Wilkinson AA; Dudzic EM; Matte GG; Outerbridge CA; Schmon CL; Ihle SL
J Am Vet Med Assoc; 1996 Nov; 209(10):1733-6. PubMed ID: 8921031
[TBL] [Abstract][Full Text] [Related]
34. Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocol.
Rubello D; Fig LM; Casara D; Piotto A; Boni G; Pelizzo MR; Shapiro B; Sandrucci S; Gross MD; Mariani G;
Cancer Biother Radiopharm; 2006 Jun; 21(3):194-205. PubMed ID: 16918295
[TBL] [Abstract][Full Text] [Related]
35. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal localization strategy.
Peeler BB; Martin WH; Sandler MP; Goldstein RE
Am Surg; 1997 Jan; 63(1):37-46. PubMed ID: 8985069
[TBL] [Abstract][Full Text] [Related]
36. [99m-Tc-MIBI SPECT parathyroid gland scintigraphy for the preoperative localization of small parathyroid gland adenomas].
Moka D; Voth E; Larena-Avellaneda A; Schicha H
Nuklearmedizin; 1997 Oct; 36(7):240-4. PubMed ID: 9441283
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT.
Perez-Monte JE; Brown ML; Shah AN; Ranger NT; Watson CG; Carty SE; Clarke MR
Radiology; 1996 Oct; 201(1):85-91. PubMed ID: 8816526
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid Carcinoma Shown on 99mTc-Sestamibi Parathyroid SPECT/CT Scan in a Pediatric Patient.
Wang W; Liu J; Liu J; Yang J
Clin Nucl Med; 2020 Jun; 45(6):480-482. PubMed ID: 32209876
[TBL] [Abstract][Full Text] [Related]
39. Functional imaging using PET and SPECT in pediatric neurology.
Messa C; Grana C; Lucignani G; Fazio F
J Nucl Biol Med (1991); 1994 Mar; 38(1):85-8. PubMed ID: 8075181
[No Abstract] [Full Text] [Related]
40. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
